However, lncRNA FOXD2‐AS1 overexpression elevated tumour growth and weight as well as shortened survival, which was blocked by oe‐lncRNA FOXD2‐AS1 + sh‐TAF‐1 (Fig. S4A, Figure 5B‐D). Here, FOXD2 is linked to neoplasm.